Supplementary Figure S3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Dario Callegaro; Gabriele Tinè; Felix Boakye Oppong; Axelle Nzokirantevye; Saskia Litière; Stefano Percio; Andrea Carenzo; Loris De Cecco; Frédéric Chibon; Silvia Brich; Alessia Bertolotti; Paola Collini; Anna Maria Frezza; Paul H. Huang; Rick L. Haas; Sylvie Bonvalot; Winan J. van Houdt; Rosalba Miceli; Sandro Pasquali; Alessandro Gronchi

doi:10.1158/1078-0432.29760964

Key Points

Predicted overall survival and disease free survival are assessed using Sarculator for sarcoma patients.
Data shows median predicted OS/DFS at 5 and 10 years is affected by CINSARC risk categories.
Boxplot visualizations illustrate the distribution of survival predictions among different risk groups.
Findings may help guide treatment decisions based on predicted outcomes in sarcoma patients.

Implication

Boxplot analysis reveals predicted overall survival and disease free survival in sarcoma patients, indicating risk categorization impacts outcomes.

Abstract

Supplemental Figure 3: boxplot showing the distribution of Sarculator predicted overall survival (A, C) and Sarculator predicted disease free survival (B, D) at 5 years (A, B) and at 10 years (C, D) stratified by CINSARC risk category (blue, C1; yellow, C2). The median predicted OS/DFS is marked by the central horizontal line in each box with the box edges representing the interquartile range.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Callegaro et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0156 https://doi.org/10.1158/1078-0432.29760964

View Full Paper

Ask AI

Bookmark

Share

Supplementary Figure S3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Key Points

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure S3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading